Results 161 to 170 of about 1,997 (174)

† Lomitapide in pediatric patients with HoFH – analysis of long-term (104-week) safety and efficacy from the APH-19 study

Journal of Clinical Lipidology
Alberto Zambon, C. Schmitt, C. Taylan, J. Driemeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, M. Al-Dubayee, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Naji Kholaif, S. Löwe, Zsuzsanna Tamas, Luis Masana   +15 more
semanticscholar   +1 more source

Pharmacokinetics and Pharmacodynamics of Lomitapide in Japanese Subjects

Journal of Atherosclerosis and Thrombosis, 2016
Jorg Taubel, Ulrike Lorch
exaly  

Lomitapide: navigating cardiovascular challenges with innovative therapies

Molecular Biology Reports
U. Munkhsaikhan, K. Ait-Aissa, Amal M. Sahyoun, E. Apu, A. Abidi, A. Kassan, M. Kassan   +6 more
semanticscholar   +1 more source

Safety and Efficacy of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH): Results from the AEGR-733-301 Long-Term Extension Study

Journal of Atherosclerosis and Thrombosis, 2019
Atsushi Nohara, Masayuki Yoshida
exaly  

Lomitapide for use in patients with homozygous familial hypercholesterolemia: a narrative review

Expert Review of Clinical Pharmacology, 2016
Ioanna Gouni-Berthold, Heiner Berthold
exaly  

Lomitapide for the treatment of homozygous familial hypercholesterolaemia in children.

The Lancet Diabetes and Endocrinology
L. Brunham, R. Hegele
semanticscholar   +1 more source

The long-term, real-world effectiveness and safety of lomitapide in homozygous familial hypercholesterolaemia (HoFH): Nine-year data from the lomitapide observational worldwide evaluation registry (lower)

Atherosclerosis
Dirk Blom, J. Cegla, J. Underberg, Christopher Cannon, Dominique Larrey, Lukas Makris, Sallyann O'Brien   +6 more
semanticscholar   +1 more source

The Lomitapide Observational Worldwide Evaluation Registry (LOWER) - Nine-year Effectiveness and Safety Data in HoFH

Journal of Clinical Lipidology
J. Underberg, Christopher Cannon, Dominique Larrey, Lukas Makris, Sallyann O'Brien, Dirk Blom   +5 more
semanticscholar   +1 more source

Lomitapide/warfarin

Reactions weekly

semanticscholar   +1 more source

299 (PB287): Lomitapide enhances cytotoxic effects of temozolomide in chemoresistant glioblastoma

European Journal of Cancer
A. Ivanova, T. Wilson, K. Ghannad-Zadeh, E. Tse, M. Wu, S. Das   +5 more
semanticscholar   +1 more source